Home/Publication/Lanchi Doubles Down on Treatment for Metabolic Diseases
Lanchi Doubles Down on Treatment for Metabolic Diseases 

25 Feb 2025

US$ 20.00

Lanchi Ventures has made a follow-on investment in the latest Rmb100 million (US$13.8 million) financing round of ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly for the week ending 28 Feb 2025...

Listen to Subscribers' Weekly 28 Feb 2025...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.